The molecular basis of the human serum paraoxonase activity polymorphism.
about
Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigationsReconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesteraseDNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart diseaseParaoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicityAssociation between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyThe association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysisThe role of genetic polymorphisms in environmental health.Increased influence of genetic variation on PON1 activity in neonates.Neurologic function among termiticide applicators exposed to chlorpyrifosParaoxonase-1 and early-life environmental exposuresThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisRecent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental healthNo association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese populationPolymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphatesPharmacogenomic considerations of the paraoxonase polymorphismsParaoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetesEffects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 statusHuman PON1, a biomarker of risk of disease and exposureParaoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newbornsParaoxonase 1 activities and polymorphisms in autism spectrum disordersAssociations of maternal organophosphate pesticide exposure and PON1 activity with birth outcomes in SAWASDEE birth cohort, ThailandMechanisms underlying Children's susceptibility to environmental toxicantsIdentification of genetic and chemical modulators of zebrafish mechanosensory hair cell deathParaoxonase 1 and homocysteine metabolism.Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment.Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.Adaptations to climate in candidate genes for common metabolic disordersCYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control studyThe role of phosphotriesterases in the detoxication of organophosphorus compounds.Genome-wide SNP analysis of the Systemic Capillary Leak Syndrome (Clarkson disease).Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerPolymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study.Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese womenParaoxonase genes and disease.High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis.Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy malesParaoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue.
P2860
Q23923020-A9E63F87-9224-4886-94D3-8BDC546CD36FQ24322715-ED66C80D-083E-4537-B167-B8EB577A3886Q24538662-28F8A94B-11CF-4995-8A19-D7B0A788F3F3Q24602455-7A48181D-3254-45E4-98E9-D21F7B1397D3Q24615705-EAA48BFB-6A0C-49F2-AAE3-A2DE6C4209E7Q24801635-E7942BBE-AA78-4DE2-9A8B-C3DAB72F44A9Q24815139-175A8CFC-55CB-4944-BF88-8BD5D9E03CE0Q24815868-BCEA7E8A-38D0-4760-A03B-46B77CEAB9ECQ26343705-13D846BF-FB44-4DA8-A9AA-B925852E1C2FQ26744234-F28A1969-0AC1-4056-AE67-D61069F06F00Q26824356-13B3230E-486A-4B7C-9869-91FE2CF3518EQ26830910-C3600AA3-0551-49B5-9800-1CF7988335A2Q28139302-28F03A95-5D66-433E-883B-402E3CD7664CQ28184693-CFD83C99-418D-4F3F-A4F9-DB9CCB60E366Q28203018-38EF570B-88A8-4873-B33F-E4CC0C927DC3Q28210667-E0157E0F-D4C4-4218-8656-35B44D40473BQ28364175-473B92D8-6FC9-436A-B80F-2E42B5FF2451Q28383254-40CB6643-27A5-4B27-9E86-98E3743D5C53Q28386121-02A303FA-0290-4C96-BCFC-310F08ABED2EQ28386131-43D04E65-42B9-45B0-9658-917BF60D5CFAQ28389567-F89F4CE9-C217-46E9-B58D-EFC4DCD3CB3EQ28390802-6B01198B-BFBC-42A1-BED3-2C10F9C0BB36Q28391428-24621C35-087A-4AA3-95F7-4AC8120A097CQ28391945-E14227AC-B70A-4823-8DC4-02ABC52E931CQ28472316-F48DB643-9AA0-4B17-92D1-30761565F340Q30417352-7AFE6DC9-39B5-4474-B921-907DFFF263F8Q30925847-1797662B-D20A-4677-957B-655C5446E75BQ33237181-AE2274D2-210F-4741-917C-674AF7C97A7BQ33278805-0D4CC822-A331-4E8D-97D6-DC35791B7DE3Q33320199-1644E4E6-7664-4A2C-8B26-4D1C5E97BEBBQ33432351-5804E85B-F4F9-4DDF-A5FD-99CCF4451BC8Q33538521-7BB76176-44C6-4B52-9BAA-4B6A3CF89D01Q33564561-02396333-9435-4225-961E-3B78FF1FC54FQ33608783-F81F1C74-C8D8-4949-98D2-C8ABF7D5909DQ33645551-EB331EA9-5817-4777-BC1E-2808E8741837Q33648880-08F86565-950D-4275-AD88-0D51046E5246Q33708692-225E1183-8ED9-4A80-8B70-A51522EBCE33Q33806840-46345FD9-CDF5-44BD-A708-90AC4F62061CQ33898495-3EB1A7FB-C9EE-41DC-BF30-1A4364C94A4FQ33902049-0C47EDDE-1FD6-48D5-8415-48EE87580D64
P2860
The molecular basis of the human serum paraoxonase activity polymorphism.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
The molecular basis of the human serum paraoxonase activity polymorphism.
@en
The molecular basis of the human serum paraoxonase activity polymorphism.
@nl
type
label
The molecular basis of the human serum paraoxonase activity polymorphism.
@en
The molecular basis of the human serum paraoxonase activity polymorphism.
@nl
prefLabel
The molecular basis of the human serum paraoxonase activity polymorphism.
@en
The molecular basis of the human serum paraoxonase activity polymorphism.
@nl
P2093
P2860
P356
P1433
P1476
The molecular basis of the human serum paraoxonase activity polymorphism.
@en
P2093
C E Furlong
C J Omiecinski
C M Disteche
P2860
P2888
P356
10.1038/NG0193-73
P407
P577
1993-01-01T00:00:00Z